Santé log35 分钟
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of ...
In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at the Obesity Society Annual Meeting (ObesityWeek) 2024. For the presentation ...